Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says - CNBC
The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk's Wegovy and Eli Lilly's Zepbound.
Comments